DexCom stock crashed after the company reported disappointing Q2 results and cut its full-year guidance. This performance raised questions about the potential impact of GLP-1 drugs on DexCom's ...
Dexcom’s stock slid by about 40% following its second-quarter earnings report after the diabetes sensor maker said it saw not only fewer customers but also fewer dollars per customer—driving revenue ...
ARLINGTON, VA / ACCESS Newswire / August 13, 2025 / FriskaAi announced today an agreement with DexCom, Inc., the global leader in glucose biosensing, to integrate data from Dexcom G7 and Dexcom G6 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results